BRIGHT provided funding to support a phase II randomized trial to evaluate the safety of two accelerated partial breast irradiation regimens,...

Hereditary breast cancer accounts for 5-10% of all breast cancer diagnoses and is primarily caused by changes (mutations) in two genes called...

Imaging of the breast is an important tool in the early detection, diagnosis and monitoring of response to treatment in breast cancer....

Approximately 30% of women who present with early breast cancer undergo mastectomy. The results of randomized clinical trials have shown that...